3652 results for «231»
3652 results
The most impactful trials of 2025
10 Dec 2025 – From GulfPCR-GIM 2025
Review the most impactful cardiovascular intervention trials anticipated in 2025, analyzing their methodology and clinical applicability. This session facilitates understanding how emerging evidence can be integrated into daily interventional cardiology practice.
Challenging TAVI cases - Part 1
10 Dec 2025 – From GulfPCR-GIM 2025
Addressing complex TAVI cases, this session focuses on procedural challenges and advanced strategies to optimize safety and outcomes. Topics include high-risk valvuloplasty, management with prosthetic valves, and considerations in patients with valve thrombus.
Complex CTO interventions - Part 1
10 Dec 2025 – From GulfPCR-GIM 2025
Explore advanced techniques in complex chronic total occlusion (CTO) interventions, featuring IVUS-guided retrograde wire facilitated antegrade approaches, novel multiwire plaque modification for uncrossable in-stent restenosis CTOs, and strategic navigation through challenging scenarios. This session highlights key procedural insights and complication management strategies essential for success in...
GulfPCR-GIM 2025 Opening Ceremony
10 Dec 2025 – From GulfPCR-GIM 2025
The GulfPCR-GIM 2025 Opening Ceremony marks the commencement of this prestigious cardiology congress, setting the tone for a comprehensive program dedicated to advancing interventional cardiology practice and research in the Gulf region and beyond.
GulfPCR-GIM 2025 Closing Ceremony
11 Dec 2025 – From GulfPCR-GIM 2025
The GulfPCR-GIM 2025 Closing Ceremony marks the conclusion of an insightful and comprehensive congress, highlighting the latest advances and discussions in interventional cardiology. This session encapsulates the key takeaways and emerging themes that will shape future clinical practice and research in cardiology.
Seeing is believing: OCT-guided calcium modification in complex PCI
10 Dec 2025 – From GulfPCR-GIM 2025
Explore the management of heavily calcified LAD lesions in this PCRGulf-GIM 2025 session. Discover how OCT imaging guides lesion assessment, differentiates superficial from deep calcium, and informs the need for plaque modification. Learn when and how to use orbital atherectomy or intravascular lithotripsy, and follow the...
Beyond the trial: how will SELUTION DeNovo redefine our PCI practice?
10 Dec 2025 – From GulfPCR-GIM 2025
This session looks beyond trial data to examine how the SELUTION DeNovo study may reshape PCI practice in real-world settings.
The discussion reviews key clinical results from this large-scale DeNovo PCI trial and explains the technology behind the SELUTION SLR drug-eluting balloon, including its slow-flow drug delivery...
Cracking calcium in modern PCI
10 Dec 2025 – From GulfPCR-GIM 2025
Calcified coronary lesions are a major challenge in PCI. This PCRGulf-GIM 2025 session showcases a complex case with intravascular imaging, highlighting how IVUS 123 guides each step.
From planning the procedure and understanding calcium distribution, to lesion preparation with modern modification tools, and post-PCI assessment to confirm...
PCR Tokyo Valves 2026: Your travel guide featuring upcoming exclusive booking services and special deals.
Percutaneous or surgical management of post-infarction ventricular septal defects: The United Kingdom National Registry
17 Sep 2022
Elad Asher provides his take on the UK National Registry which was presented at the TCT congress 2022 by Joel Peter Giblett on behalf of the UK PIVSD investigators.
Author
OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease
04 Nov 2021
Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.
Author
EuroPCR 2026 – Long-term mortality following revascularisation for left main disease
20 May 2026
Paris, France, 19−22 May 2026. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide. Among them is a meta-analysis of long-term data from 4 randomised trials investigating...
